PHARMACY

Ohio looks to Appriss Health for PDMP enhancement

BY David Salazar

LOUISVILLE, Ky. — The State of Ohio Board of Pharmacy is partnering with Appriss Health to bolster the state’s prescription drug monitoring program, the Ohio Automated Rx Reporting System, or OARRS. The reporting system will now offer access to Appriss Health’s NarxCare analytics and patient support platform to pharmacists and prescribers within their clinical workflow and through OARRS.

“This is another step in our commitment to utilize data in OARRS to better inform patient care,” State of Ohio Board of Pharmacy executive eirector Steven Schierholt said.

Ohio also uses Appriss Health’s PMP Gateway, which allows prescribers and pharmacies to access PDMP data through EHRs and pharmacy management systems. The PMP Gateway includes audit trail access, multi-state PDMP data within a workflow and more, in addition to the NarxCare platform, Appriss Health said.

“Ohio has long taken an aggressive and leading role towards addressing substance use disorder within its communities,” said Rob Cohen, President, Appriss Health. “Today, once again, Ohio has significantly strengthened its prescription drug monitoring program to give prescribers and pharmacists greater ability to help identify, manage, and prevent prescription drug abuse. Ohio’s forward-thinking leadership is at the forefront of facilitating earlier interventions, and better clinical outcomes, that can ultimately save lives.”

The implementation of Appriss Health’s technology was supported through the Centers for Medicare and Medicaid Services, which administers the Health Information Technology for Economic and Clinical Health Act.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Two-thirds of adults are not up-to-date on their vaccines, survey finds

BY Michael Johnsen

LONDON — Despite the World Health Organization citing immunization as one of the most powerful and cost-effective interventions in public health, a new survey conducted by Ipsos MORI and sponsored by GSK Vaccines in Brazil, Germany, India, Italy and the United States found that 68% of adults are not up-to-date with the vaccines recommended for them.

Almost three in 10 adults report not having had any of the vaccines potentially relevant to them within the past five years.

Findings from the Vaccinate for Life survey of 6,002 adults aged 18 years and over, carried out across five countries also found that as many as 15% of adults believe that vaccinations are only recommended for children and/or babies with 21% thinking they are only needed for travel purposes.
    
"Although mostly associated with childhood, vaccination is not something you outgrow," stated Susanna Esposito, full professor at the University of Perugia, Italy, and infectious disease specialist. "As we age, so does our immune system and we become more susceptible to infectious diseases which could be prevented through vaccination. It is important that [healthcare practitioners] are aware of the possible benefits of adult vaccination and discuss it with their patients."

Findings from the Vaccinate for Life survey show that when asked to consider why they are not up-to-date, people cite lack of recommendations and/or discussion from their HCP about the need for vaccines in adult life. They say that they would find a range of information sources useful to help them understand, record and track the vaccinations which may be relevant to them.

"Vaccination throughout life can help protect and contribute to the wellbeing of individuals families and communities," said Thomas Breuer, chief medical officer, GSK Vaccines. "What the Vaccinate for Life survey shows us is that adults need more information on the vaccines relevant to them to help them be more proactive in discussing their vaccination needs with their healthcare professional."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

H.D. Smith inks partnership with ESPhA

BY David Salazar

SPRINGFIELD, Ill., and NASHVILLE, Tenn. — Independent wholesaler H.D. Smith has a new partnership with group purchasing organization Enhanced Service Pharmacy Alliance, or ESPhA. The partnership brings ESPhA members access to H.D. Smith’s full product line, which includes 9,000-item generic pharmaceutical formulary, and access to the company’s consultant-style account management strategy.

“Our strategic account executives are armed with information, vendors, programs and solutions to help independent pharmacies find their niche in a community and thrive,” H.D. Smith president and CEO Chris Smith said. “By partnering with like-minded pharmacies who are searching for this kind of consultative relationship, we can develop a true ‘win-win’ for both sides. Because we have been supporting independent pharmacies since our founding in 1954, H. D. Smith was a natural fit for this group of driven, community-focused pharmacists.”

ESPhA said it was founded in an effort to make community pharmacies adaptable to a changing healthcare system. The group purchasing organization said it assists its members in implementing enhanced pharmacy services. In addition to the new H.D. Smith Partnership, ESPhA also partners with MedHere Today Consulting, which it said allows it to offer a support system to its members.

“ESPhA’s unique services create opportunities for pharmacists to see beyond the prescription counter, past the day-to-day struggle with reimbursement and DIR issues, and focus on the future of their pharmacy practice,” ESPhA CEO Alan Wilson said. “It is ESPhA’s mission to not only ready our pharmacy members for performance in a quality-driven health environment, but to identify, and even help develop, new, clinically relevant revenue streams for the pharmacy.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?